Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis

BACKGROUND: The treatment of rheumatoid arthritis is based on the use of disease-modifying antirheumatic drugs (DMARDs). Tocilizumab can be used as monotherapy or in combination with conventional synthetic DMARDs for the treatment of moderate-to-severe active rheumatoid arthritis. Subcutaneous (SC)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am Health Drug Benefits
Egile Nagusiak: Punekar, Rajeshwari, Choi, Jeannie, Boklage, Susan, Iglesias-Rodriguez, Melitza, Nola, Kamala
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Engage Healthcare Communications, LLC 2019
Gaiak:
Clinical
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986546/
https://ncbi.nlm.nih.gov/pubmed/32030116
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak